Issue Type: R&D Investment Prioritizes Profitability Over Public Health and Innovation

in challenge narrative

  • Evaluating Industry’s Drug Pricing Claims

  • Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle

  • After 4 Years of Trump, Medicare and Medicaid Badly Need Attention

  • Profitability over Public Health and Innovation

  • Incentives for Rare Diseases: the Right Healthcare Priorities?

  • Time to Throw in the Towel on Biosimilars

  • DPL and Collaborators to Publish Drug Pricing Primer Series

  • Billion-Dollar Babies

  • Is Profit or Innovation Driving the Rising Costs of Drugs?

  • Dr. Peter Bach Explains How Increasing Drug Prices Stifles Innovation